Skip to main content
. 2021 Dec 21;15(1):6. doi: 10.3390/ph15010006

Figure 3.

Figure 3

Cytotoxicity effect analysis of MDA-MB-231 (AC) and SKBR3 (DF) cell lines against different fabricated niosomal and non-niosomal formulation treatments in 48 h (A,D) and 72 h (B,E) by various concentration and calculated IC50 concentrations by linear interpolation of each sample for MDA-MB-231 (C) and SKBR3 (F) ** p < 0.01, and **** p < 0.0001).